Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 14:12:03073.
doi: 10.7189/jogh.12.03073.

COVID-19 in Japan during 2020-2022: Characteristics, responses, and implications for the health care system

Kenji Karako  1 , Peipei Song  2 , Yu Chen  1 , Takashi Karako  3
Affiliations

COVID-19 in Japan during 2020-2022: Characteristics, responses, and implications for the health care system

Kenji Karako et al. J Glob Health. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure of interest: The authors completed the ICMJE Disclosure of Interest Form (available upon request from the corresponding author) and disclose no relevant interests.

Figures

Figure 1
Figure 1
Number of reported COVID-19 cases, national response to the pandemic, and the vaccination campaign in Japan from 2020-2022. Data source: https://www.mhlw.go.jp/stf/covid-19/open-data.html, https://www.kantei.go.jp/jp/headline/kansensho/vaccine.html.
None
Photo: Shibuya Scramble Crossing, Tokyo (from the fourth author’s own collection, used with permission).
Figure 2
Figure 2
Changes in (A) number of inpatients, (B) medical expenses associated with hospitalization, (C) number of outpatients, and (D) medical expenses for outpatients in public hospitals in Japan from January 2009 to December 2021.
See this image and copyright information in PMC

References

    1. Tallei TE, Alhumaid S, AlMusa Z, Fatimawali, Kusumawaty D, Alynbiawi A, et al. Update on the omicron sub-variants BA.4 and BA.5. Rev Med Virol. 2022;e2391. 10.1002/rmv.2391 - DOI - PMC - PubMed
    1. Takashita E, Yamayoshi S, Simon V, van Bakel H, Sordillo EM, Pekosz A, et al. Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants. N Engl J Med. 2022;387:468-70. 10.1056/NEJMc2207519 - DOI - PMC - PubMed
    1. Joung SY, Ebinger JE, Sun N, Liu Y, Wu M, Tang AB, et al. Awareness of SARS-CoV-2 Omicron Variant Infection Among Adults With Recent COVID-19 Seropositivity. JAMA Netw Open. 2022;5:e2227241. 10.1001/jamanetworkopen.2022.27241 - DOI - PMC - PubMed
    1. The World Health Organization. WHO Coronavirus (COVID-19) Dashboard (as of August 19, 2022). 2022. Available: https://covid19.who.int. Accessed: 20 August 2022.
    1. Ministry of Health, Labor, and Welfare. New coronavirus infection in Japan (as of 19 August 2022 (in Japanese). 2022. Available: https://www.mhlw.go.jp/stf/newpage_27487.html. Accessed: 20 August 2022.